Critical Role for Polar Residues in Coupling Leukotriene B4 Binding to Signal Transduction in Blt1.
From: Tumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville Health Sciences, Louisville, Kentucky 40202, USA.
The Journal of biological chemistry
- Publish Date: Mar 2007
- ISSN: 0021-9258
- Volume: 282
- Issue: 13
- Pages: 10005-17
- Medium: Print
- Language: English
- Citation (JAMA): Basu Sudeep, Jala Venkatakrishna R, Mathis Steven, et al. Critical Role for Polar Residues in Coupling Leukotriene B4 Binding to Signal Transduction in Blt1.. J. Biol. Chem. Mar 2007;282:10005-17
Abstract
Leukotriene B(4) (LTB(4)) mediates a variety of inflammatory diseases such as asthma, arthritis, atherosclerosis, and cancer through activation of the G-protein-coupled receptor, BLT1. Using in silico molecular dynamics simulations combined with site-directed mutagenesis we characterized the ligand binding site and activation mechanism for BLT1. Mutation of residues predicted as potential ligand contact points in transmembrane domains (TMs) III (H94A and Y102A), V (E185A), and VI (N241A) resulted in reduced binding affinity. Analysis of arginines in extracellular loop 2 revealed that mutating arginine 156 but not arginine 171 or 178 to alanine resulted in complete loss of LTB(4) binding to BLT1. Structural models for the ligand-free and ligand-bound states of BLT1 revealed an activation core formed around Asp-64, displaying multiple dynamic interactions with Asn-36, Ser-100, and Asn-281 and a triad of serines, Ser-276, Ser-277, and Ser-278. Mutagenesis of many of these residues in BLT1 resulted in loss of signaling capacity while retaining normal LTB(4) binding function. Thus, polar residues within TMs III, V, and VI and extracellular loop 2 are critical for ligand binding, whereas polar residues in TMs II, III, and VII play a central role in transducing the ligand-induced conformational change to activation. The delineation of a validated binding site and activation mechanism should facilitate structure-based design of inhibitors targeting BLT1.
Mesh Headings (Keywords): Amino Acid Sequence, Amino Acid Substitution, Amino Acids, Animals, Binding Sites, Cattle, Humans, Leukotriene B4, Ligands, Molecular Sequence Data, Protein Binding, Receptors, Leukotriene B4, Signal Transduction
Check for Full Text / PubMed Unique Identifier (PMID): 17237498
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.